Snowden Capital Advisors LLC Catalent, Inc. Transaction History

Snowden Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $753 - $995	-8 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $956 - $1,112	8 New	8 $1,000
Q3 2021 Feb 05, 2024	BUY	$109.17 - $142.35 $200,436 - $261,354	1,836 New	1,836 $244 Million
Q1 2020 Jan 08, 2024	SELL	$36.95 - $62.95 $3.67 Million - $6.25 Million	-99,300 Closed	0 $0
Q4 2019 Jan 08, 2024	BUY	$47.06 - $56.64 $4.67 Million - $5.62 Million	99,300 New	99,300 $55.9 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.